Trial of octacosanol in amyotrophic lateral sclerosis

Abstract
Octacosanol was tried in amyotrophic lateral sclerosis in a double-blind, placebo-controlled, crossover design. Neurologic and pulmonary function evaluations showed no benefit.

This publication has 0 references indexed in Scilit: